Significance of miRNAs on the thyroid cancer progression and resistance to treatment with special attention to the role of cross-talk between signaling pathways
Thyroid cancer (TC) is the most prevalent endocrine malignant tumor. It has many types, the
Papillary thyroid cancer (PTC)(most common and follicular thyroid carcinoma (FTC). Several …
Papillary thyroid cancer (PTC)(most common and follicular thyroid carcinoma (FTC). Several …
2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association …
BR Haugen, EK Alexander, KC Bible, GM Doherty… - Thyroid, 2016 - liebertpub.com
Background: Thyroid nodules are a common clinical problem, and differentiated thyroid
cancer is becoming increasingly prevalent. Since the American Thyroid Association's …
cancer is becoming increasingly prevalent. Since the American Thyroid Association's …
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
MS Brose, CM Nutting, B Jarzab, R Elisei, S Siena… - The Lancet, 2014 - thelancet.com
Background Patients with radioactive iodine (131 I)-refractory locally advanced or metastatic
differentiated thyroid cancer have a poor prognosis because of the absence of effective …
differentiated thyroid cancer have a poor prognosis because of the absence of effective …
BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence
Purpose To investigate the prognostic value of the BRAF V600E mutation and the recently
identified TERT promoter mutation chr5: 1,295,228 C> T (C228T), individually and in their …
identified TERT promoter mutation chr5: 1,295,228 C> T (C228T), individually and in their …
Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer
M Xing, AS Alzahrani, KA Carson, YK Shong… - Journal of clinical …, 2015 - ascopubs.org
Purpose To investigate the prognostic value of BRAF V600E mutation for the recurrence of
papillary thyroid cancer (PTC). Patients and Methods This was a retrospective multicenter …
papillary thyroid cancer (PTC). Patients and Methods This was a retrospective multicenter …
[HTML][HTML] Highly prevalent TERT promoter mutations in aggressive thyroid cancers
Abstract Mutations 1 295 228 C> T and 1 295 250 C> T (termed C228T and C250T
respectively), corresponding to− 124 C> T and− 146 C> T from the translation start site in the …
respectively), corresponding to− 124 C> T and− 146 C> T from the translation start site in the …
[PDF][PDF] SNMMI procedure standard/EANM practice guideline for nuclear medicine evaluation and therapy of differentiated thyroid cancer: abbreviated version
AM Avram, L Giovanella, B Greenspan, SA Lawson… - 2022 - Soc Nuclear Med
Editor's note: SNMMI and the European Association of Nuclear Medicine periodically define
new standards/guidelines for nuclear medicine practice to help advance the science of …
new standards/guidelines for nuclear medicine practice to help advance the science of …
Retinoic acid receptors: from molecular mechanisms to cancer therapy
Retinoic acid (RA), the major bioactive metabolite of retinol or vitamin A, induces a spectrum
of pleiotropic effects in cell growth and differentiation that are relevant for embryonic …
of pleiotropic effects in cell growth and differentiation that are relevant for embryonic …
Novel fibroblast activation protein inhibitor-based targeted theranostics for radioiodine-refractory differentiated thyroid cancer patients: a pilot study
Background: This exploratory study was meant to assess clinical and safety data with a
novel fibroblast activation protein inhibitor-based targeted theranostics as a salvage …
novel fibroblast activation protein inhibitor-based targeted theranostics as a salvage …
Mortality risk stratification by combining BRAF V600E and TERT promoter mutations in papillary thyroid cancer: genetic duet of BRAF and TERT promoter mutations in …
Importance BRAF V600E andTERTpromoter mutations can coexist in papillary thyroid
cancer (PTC). This genetic duet was indicated to be involved in the aggressiveness of PTC …
cancer (PTC). This genetic duet was indicated to be involved in the aggressiveness of PTC …